# Comparison of Hyperemic Efficacy Between Nicorandil and Adenosine for Fractional Flow Reserve (FFR) Measurement

> **NCT01331902** · PHASE4 · UNKNOWN · sponsor: **Seoul National University Hospital** · enrollment: 200 (estimated)

## Conditions studied

- Coronary Artery Disease
- Myocardial Ischemia

## Interventions

- **OTHER:** Maximal Hyperemia with Adenosine Followed by Nicorandil
- **OTHER:** Maximal Hyperemia with Nicorandil Followed by Adenosine

## Key facts

- **NCT ID:** NCT01331902
- **Lead sponsor:** Seoul National University Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2011-03
- **Primary completion:** 2011-09
- **Final completion:** 2011-09
- **Target enrollment:** 200 (ESTIMATED)
- **Last updated:** 2011-04-08

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01331902

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01331902, "Comparison of Hyperemic Efficacy Between Nicorandil and Adenosine for Fractional Flow Reserve (FFR) Measurement". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT01331902. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*